NEW YORK, April 6 (GenomeWeb News) - Beckman Coulter and the Research in Immune Tolerance and Transplantation program, a $10-million initiative funded by the Canadian government and others, will jointly conduct research to develop tests for use in transplantation, the company said today.
Under the two-year agreement, Beckman will support a postdoctoral scientist, provide funding for new reagent combinations, sponsor symposiums and workshops, and help the RITT program to secure additional funding.
In return, Beckman will receive first rights to new discoveries resulting from the collaboration. RITT will also acquire over $1 million worth of separation and analysis equipment from Beckman.
The research will be conducted at the RITT Industrial Biodevelopment Laboratory at the Toronto General Hospital in Canada.